Kết quả tìm kiếm - Vipin Yadav
- Đang hiển thị 1 - 8 kết quả của 8
-
1
Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration Bằng Vipin Yadav, Mitchell F. Denning
Được phát hành 2010Artigo -
2
-
3
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 Bằng Jennifer M. Atkinson, Kenneth B. Rank, Yi Arial Zeng, Andrew Capen, Vipin Yadav, Jason R. Manro, Thomas A. Engler, Márcio F. Chedid
Được phát hành 2015Artigo -
4
Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma Bằng Vipin Yadav, Xiaoyi Zhang, Jiangang Liu, Shawn T. Estrem, Shuyu Li, Xueqian Gong, Sean G. Buchanan, James R. Henry, James J. Starling, Sheng-Bin Peng
Được phát hành 2012Artigo -
5
The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation Bằng Vipin Yadav, Teresa F. Burke, Lysiane Huber, Robert D. Van Horn, Youyan Zhang, Sean G. Buchanan, Edward M. Chan, James J. Starling, Richard P. Beckmann, Sheng-Bin Peng
Được phát hành 2014Artigo -
6
Oncogenic <i>BRAF</i> Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120 Bằng Shih-Hsun Chen, Youyan Zhang, Robert D. Van Horn, Tinggui Yin, Sean G. Buchanan, Vipin Yadav, Igor Mochalkin, Swee Seong Wong, Yong Yue, Lysiane Huber, Ilaria Conti, James R. Henry, James J. Starling, Gregory D. Plowman, Sheng-Bin Peng
Được phát hành 2016Artigo -
7
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets Bằng Ying Chen, Jeremy McGee, Xian‐Ming Chen, Thompson N. Doman, Xueqian Gong, Youyan Zhang, Nicole Hamm, Xiwen Ma, Richard E. Higgs, Shripad V. Bhagwat, Sean G. Buchanan, Sheng-Bin Peng, Kirk A. Staschke, Vipin Yadav, Yong Yue, Hosein Kouros‐Mehr
Được phát hành 2014Artigo -
8
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers Bằng Sheng-Bin Peng, James R. Henry, Michael D. Kaufman, Wei-Ping Lu, Bryan D. Smith, Subha Vogeti, Thomas J. Rutkoski, Scott Wise, Lawrence Chun, Youyan Zhang, Robert D. Van Horn, Tinggui Yin, Xiaoyi Zhang, Vipin Yadav, Shih-Hsun Chen, Xueqian Gong, Xiwen Ma, Yue Webster, Sean G. Buchanan, Igor Mochalkin, Lysiane Huber, Lisa Kays, Gregory P. Donoho, Jennie Walgren, Denis McCann, Phenil J. Patel, Ilaria Conti, Gregory D. Plowman, James J. Starling, Daniel L. Flynn
Được phát hành 2015Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Biology
Cancer research
Cell biology
Genetics
Melanoma
Metastatic melanoma
Vemurafenib
Biochemistry
Gene
Kinase
MAPK/ERK pathway
Mutation
Cancer
Chemistry
KRAS
Carcinogenesis
Cell culture
Internal medicine
Medicine
Molecular biology
Neuroblastoma RAS viral oncogene homolog
Signal transduction
Trametinib
AXIN2
Amplicon
Antifungal
Autocrine signalling
Autophosphorylation
Azole
Candida albicans